相关实验视频

Updated: Jan 6, 2026

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

在消化系统瘤中,热囊细胞表面抗原2的表达:对于抗体-药物合物来说,这是一个有前途的标

Jinru Yang¹, Fangyuan Zhang², Xing Cai³

¹Department of Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China.

|October 16, 2025

概括

热囊细胞表面抗原2 (Trop2) 在消化系统癌症中被广泛表达,与瘤类型和攻击性相关的独特模式. Trop2 是一种有前途的生物标志物和治疗点,用于晚期消化道癌症中的抗体-药物联合体.

科学领域:

在瘤学瘤学.
癌症生物学癌症生物学
翻译研究是翻译研究.

背景情况:

热细胞表面抗原2 (Trop2) 是一种在各种癌症中过度表达的跨膜糖蛋白.
Trop2在瘤的进展和对治疗的抵抗中起作用.
它在消化道癌症中的表达和临床意义尚未完全理解.

研究的目的:

为了研究消化系统癌症中Trop2表达模式.
为了确定Trop2表达的临床意义.
评估Trop2作为一个潜在的治疗目标.

主要方法:

对2370名患有胃癌,结直肠癌和胰腺癌的患者进行了回顾性分析.
通过免疫组织化学对Trop2表达的定量评估.
包括后勤回归在内的统计分析,以确定预测因素和相关性.

主要成果:

Trop2在消化系统癌症中广泛表达,特别是在胰腺癌和胃癌中.
Trop2的表达与瘤类型,结环细胞癌,血管侵袭和围神经侵袭有关.
在胃癌,结直肠癌和胰腺癌中观察到不同的Trop2表达模式,每个类型都有特定的关联.

结论:

Trop2 是一种有前途的生物标志物,用于在消化系统癌症中发现瘤的攻击性.
Trop2是抗体 - 药物联合体 (ADC) 的潜在目标,特别是在攻击性亚型中.
这些发现支持Trop2导向的ADC疗法的患者分层.

关键词:

抗体与药物结合物的结合物.消化系统的瘤.有针对性的治疗.热囊细胞细胞表面抗原2 2

更多相关视频

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.